NCT04232813View on ClinicalTrials.gov

Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

November 30, 2020

Conditions
Vulvovaginal Atrophy
Interventions
DRUG

Estradiol 10 MCG Vaginal Tablet [VAGIFEM]

To insert the tablets the patient must use the applicator provided in the way explained in the prospectus.

DRUG

Promestriene Vaginal

To insert the cream the patient must use the applicator provided in the way explained in the prospectus.

Trial Locations (1)

28009

Instituto Palacios, Madrid

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Instituto Palacios

OTHER

NCT04232813 - Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream | Biotech Hunter | Biotech Hunter